Literature DB >> 1495895

The in vitro enzymic labilities of chemically distinct phosphomonoester prodrugs.

A S Kearney1, V J Stella.   

Abstract

The kinetics of decomposition of phosphomonoesters of hydroxymethyl-5,5-diphenylhydantoin (1), estrone (2), 17 beta-testosterone (3), 1-phenylvinyl alcohol (4), and 17 alpha-testosterone (5) were studied in rat whole blood at 25 and/or 37 degrees C. As the acidity of the leaving hydroxyl group of the phosphomonoester increased, there was a tendency for the rate of hydrolysis to increase, except for the anomalous behavior of 4, which was consistent with its relative rate of hydrolysis in aqueous solutions (1). In addition, the kinetics of hydrolysis of 1-5 and p-nitrophenyl phosphate (p-NPP) were studied in the presence of isolated alkaline phosphatases from a variety of sources. The initial rate of production of 17 alpha- and 17 beta-testosterone from their respective phosphate esters (5 and 3), in the presence of human placental alkaline phosphatase, revealed that 3 was hydrolyzed 5.3-fold more rapidly than 5. This difference in reactivity might have been the result of differences in the stereochemical and/or steric nature of the two isomers. For p-NPP, 1, 2, and 4, the kcat and kcat/Km values determined in the presence of the various alkaline phosphatases showed little variation, whereas for 3, the catalytic constants, kcat and kcat/Km, were found to be dramatically less than those found for p-NPP, 1, 2, and 4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1495895     DOI: 10.1023/a:1015840329786

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  25 in total

1.  The Phosphoric-Esterase of Blood.

Authors:  M Martland; F S Hansman; R Robison
Journal:  Biochem J       Date:  1924       Impact factor: 3.857

2.  Pharmacokinetic evaluation of two dosage regimens of clindamycin phosphate.

Authors:  K I Plaisance; G L Drusano; A Forrest; R J Townsend; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

3.  Pharmacokinetic studies of clindamycin phosphate.

Authors:  R M DeHaan; C M Metzler; D Schellenberg; W D Vandenbosch
Journal:  J Clin Pharmacol       Date:  1973 May-Jun       Impact factor: 3.126

4.  Metal ion catalysis of phosphoryl transfer from phosphoenolpyruvate.

Authors:  S J Benkovic; K J Schray
Journal:  Biochemistry       Date:  1968-11       Impact factor: 3.162

5.  Bioavailability of dexamethasone. II. Dexamethasone phosphate.

Authors:  L E Hare; K C Yeh; C A Ditzler; F G McMahon; D E Duggan
Journal:  Clin Pharmacol Ther       Date:  1975-09       Impact factor: 6.875

6.  The anomalous hydrolytic behavior of 1-phenylvinyl phosphate.

Authors:  A S Kearney; V J Stella
Journal:  Pharm Res       Date:  1992-03       Impact factor: 4.200

7.  Metabolism of N-nitroso-hydroxyethyl-alkylamine phosphate esters in the rat.

Authors:  N Frank; E Frei; M Wiessler
Journal:  Toxicology       Date:  1989-07-03       Impact factor: 4.221

8.  Leaving group dependence in the phosphorylation of Escherichia coli alkaline phosphatase by monophosphate esters.

Authors:  A D Hall; A Williams
Journal:  Biochemistry       Date:  1986-08-26       Impact factor: 3.162

9.  Pharmacokinetics of estramustine phosphate (Estracyt) in prostatic cancer patients.

Authors:  P O Gunnarsson; S B Andersson; S A Johansson; T Nilsson; G Plym-Forshell
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Phenytoin prodrug 3-phosphoryloxymethyl phenytoin (ACC-9653): pharmacokinetics in patients following intravenous and intramuscular administration.

Authors:  B A Boucher; A M Bombassaro; S N Rasmussen; C B Watridge; R Achari; P Turlapaty
Journal:  J Pharm Sci       Date:  1989-11       Impact factor: 3.534

View more
  4 in total

1.  Novel cyclic phosphate prodrug approach for cytochrome P450-activated drugs containing an alcohol functionality.

Authors:  Kristiina M Huttunen; Niina Mähönen; Jukka Leppänen; Jouko Vepsäläinen; Risto O Juvonen; Hannu Raunio; Hanna Kumpulainen; Tomi Järvinen; Jarkko Rautio
Journal:  Pharm Res       Date:  2007-02-15       Impact factor: 4.200

2.  Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.

Authors:  M Safadi; R Oliyai; V J Stella
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

3.  Absorption rate limit considerations for oral phosphate prodrugs.

Authors:  Tycho Heimbach; Doo-Man Oh; Lilian Y Li; Markus Forsberg; Jouko Savolainen; Jukka Leppänen; Yasushi Matsunaga; Gordon Flynn; David Fleisher
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

4.  Phosphonooxymethyl Prodrug of Triptolide: Synthesis, Physicochemical Characterization, and Efficacy in Human Colon Adenocarcinoma and Ovarian Cancer Xenografts.

Authors:  Satish Patil; Lev G Lis; Robert J Schumacher; Beverly J Norris; Monique L Morgan; Rebecca A D Cuellar; Bruce R Blazar; Raj Suryanarayanan; Vadim J Gurvich; Gunda I Georg
Journal:  J Med Chem       Date:  2015-11-24       Impact factor: 7.446

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.